Highlights
- Market Cap
- $520.81M
- Enterprise Value
- $1.73B
- EPS (TTM)
- $2.37
- PE Ratio
- 3.72
- Total Revenue (TTM)
- $1.08B
- Gross Profit (TTM)
- $681.40M
- EBITDA (TTM)
- $338.90M
- Year Range
- $8.47 - $15.55
- Target Price
- $22.50
- ROA (TTM)
- 13.11%
- ROE (TTM)
- -22.75%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Embecta Corp, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Embecta Corp (EMBC) has returned -24.51% so far this year and -27.03% over the past 12 months.
Embecta Corp
- 1D
- 0.00%
- 1M
- -13.84%
- YTD
- -24.51%
- 6M
- -35.61%
- 1Y
- -27.03%
- 3Y*
- -29.12%
- 5Y*
- —
- 10Y*
- —
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Apr 1, 2022, EMBC's average daily return is -0.05%, while the average monthly return is -1.15%.
Historically, 38% of months were positive and 63% were negative. The best month was Nov 2024 with a return of +47.9%, while the worst month was Feb 2025 at -23.9%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 7 months.
On a daily basis, EMBC closed higher 48% of trading days. The best single day was May 9, 2024 with a return of +37.9%, while the worst single day was Dec 20, 2022 at -15.6%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -10.69% | -1.89% | -13.84% | -24.51% | |||||||||
| 2025 | -13.17% | -23.86% | -5.56% | -4.39% | -12.45% | -7.98% | 4.85% | 44.01% | -2.56% | -5.46% | -4.39% | -5.65% | -39.64% |
| 2024 | -9.46% | -15.82% | -7.07% | -23.66% | 23.54% | 1.05% | 25.36% | 5.39% | -13.71% | -0.14% | 47.94% | -0.11% | 13.56% |
| 2023 | 4.35% | 21.64% | -11.99% | -1.32% | 0.25% | -21.94% | -1.20% | -13.37% | -17.89% | 0.47% | 21.30% | 4.07% | -23.11% |
| 2022 | -0.23% | -18.57% | 2.18% | 16.23% | 8.97% | -9.81% | 7.40% | 6.47% | -22.73% | -16.21% |
Benchmark Metrics
Embecta Corp has an annualized alpha of -20.14%, beta of 0.94, and R² of 0.09 versus S&P 500 Index. Calculated based on daily prices since April 04, 2022.
- This stock participated in 149.40% of S&P 500 Index downside but only 13.03% of its upside — more exposed to losses than it benefited from rallies.
- R² of 0.09 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- -20.14%
- Beta
- 0.94
- R²
- 0.09
- Upside Capture
- 13.03%
- Downside Capture
- 149.40%
Return for Risk
Risk / Return Rank
EMBC ranks 19 for risk / return — in the bottom 19% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Embecta Corp (EMBC) and compare them to a chosen benchmark (S&P 500 Index).
| EMBC | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.52 | 0.90 | -1.41 |
Sortino ratioReturn per unit of downside risk | -0.47 | 1.39 | -1.86 |
Omega ratioGain probability vs. loss probability | 0.94 | 1.21 | -0.27 |
Calmar ratioReturn relative to maximum drawdown | -0.57 | 1.40 | -1.97 |
Martin ratioReturn relative to average drawdown | -1.19 | 6.61 | -7.79 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore EMBC risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Embecta Corp provided a 6.79% dividend yield over the last twelve months, with an annual payout of $0.60 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Dividend | $0.60 | $0.60 | $0.60 | $0.60 | $0.30 |
Dividend yield | 6.79% | 5.05% | 2.91% | 3.17% | 1.19% |
Monthly Dividends
The table displays the monthly dividend distributions for Embecta Corp. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.00 | $0.15 | $0.00 | $0.15 | |||||||||
| 2025 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2024 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2023 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.15 | $0.00 | $0.00 | $0.00 | $0.15 | $0.60 |
| 2022 | $0.15 | $0.00 | $0.00 | $0.00 | $0.15 | $0.30 |
Dividend Yield & Payout
Dividend Yield
Embecta Corp has a dividend yield of 6.79%, which means its dividend payment is significantly above the market average.
Payout Ratio
Embecta Corp has a payout ratio of 25.16%, which is below the market average. This means Embecta Corp returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Embecta Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Embecta Corp was 72.35%, occurring on Mar 27, 2026. The portfolio has not yet recovered.
The current Embecta Corp drawdown is 71.48%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -72.35% | Dec 14, 2022 | 823 | Mar 27, 2026 | — | — | — |
| -28.06% | Apr 14, 2022 | 64 | Jul 18, 2022 | 20 | Aug 15, 2022 | 84 |
| -16.63% | Aug 22, 2022 | 34 | Oct 7, 2022 | 25 | Nov 11, 2022 | 59 |
| -6.45% | Nov 14, 2022 | 4 | Nov 17, 2022 | 11 | Dec 5, 2022 | 15 |
| -6.37% | Apr 5, 2022 | 3 | Apr 7, 2022 | 1 | Apr 8, 2022 | 4 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Embecta Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Embecta Corp is priced in the market compared to other companies in the Medical Instruments & Supplies industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for EMBC, comparing it with other companies in the Medical Instruments & Supplies industry. Currently, EMBC has a P/E ratio of 3.7. This P/E ratio is considered low compared to industry peers, which may suggest that the stock is undervalued or that the company has weaker growth prospects.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for EMBC relative to other companies in the Medical Instruments & Supplies industry. Currently, EMBC has a P/S ratio of 0.5. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |